Gate2Brain is a biotech company to improve drug delivery with peptide-based patented technology.
Gate2Brain is an early-stage biotech company launched to improve drug delivery across biological barriers through the use of a radically innovative peptide-based patented technology. Its technology aims to transport drugs to the brain, increasing the efficiency and reducing the side effects of treatments for brain diseases.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 19, 2022 | Grant | €2.50M | 1 | European Innovation Council | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 4, 2020
FiscalNote
|
Series Unknown | $160M | Artificial Intelligence | — |
Dec 4, 2020
FiscalNote
|
Debt Financing | — | Artificial Intelligence | — |
Investor Name | Lead Investor | Funding Round |
---|---|---|
European Innovation Council | Yes | Grant |